Rinat Neuroscience
Palo Alto
About Rinat Neuroscience
Rinat, which means "happiness" in Hebrew, was formed in 2001 when Genentech, a leader in the development of therapeutic antibodies, narrowed its focus and spun out its key neuroscience assets under a broad license to Rinat. Genentech invested significant R&D resources in support of these assets over 15 years, and Rinat is now building on them as the pioneer in developing and commercializing antibody drugs for the treatment of diseases and disorders of the nervous system.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $57.5M
- Funding stage: M&A
- Last round: Series Unknown (Jan 2004)
- Website: rinatneuro.com
- Phone: +1 (650) 813-9250
Industries & Categories
Biotechnology, Neuroscience, Therapeutics
Canonical: https://fsome.com/organization/rinat-neuroscience-2643071 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.